Gene · 580
Papers4,139
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
521 to 540 of 4,139
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Next-Generation Sequencing and Triple-Negative Breast Cancer: Insights and Applications. | Int J Mol Sci | 2023 | 37298642 | PubTator, text mining | PubMed |
| Oncogenic Impact of TONSL, a Homologous Recombination Repair Protein at the Replication Fork, in Cancer Stem Cells. | Int J Mol Sci | 2023 | 37298484 | PubTator, text mining | PubMed |
| Target Therapy in Malignant Pleural Mesothelioma: Hope or Mirage? | Int J Mol Sci | 2023 | 37298116 | PubTator, text mining | PubMed |
| The Scarface Score: Deciphering Response to DNA Damage Agents in High-Grade Serous Ovarian Cancer-A GEICO Study. | Cancers (Basel) | 2023 | 37296992 | PubTator, text mining | PubMed |
| Pancreatic Cancer: BRCA Targeted Therapy and Beyond. | Cancers (Basel) | 2023 | 37296917 | PubTator, text mining | PubMed |
| Molecular Targeted Therapies in Metastatic Prostate Cancer: Recent Advances and Future Challenges. | Cancers (Basel) | 2023 | 37296848 | PubTator, text mining | PubMed |
| The Impact of NAD Bioavailability on DNA Double-Strand Break Repair Capacity in Human Dermal Fibroblasts after Ionizing Radiation. | Cells | 2023 | 37296639 | PubTator, text mining | PubMed |
| Prognostic stratification of endometrial cancers with high microsatellite instability or no specific molecular profile. | Front Oncol | 2023 | 37287928 | PubTator, text mining | PubMed |
| WDR4 gene polymorphisms and Wilms tumor susceptibility in Chinese children: A five-center case-control study. | J Cancer | 2023 | 37283791 | PubTator, text mining | PubMed |
| Hybrid-seq deciphers the complex transcriptional profile of the human BRCA1 DNA repair associated gene. | RNA Biol | 2023 | 37272060 | PubTator, text mining | PubMed |
| Genomic and molecular landscape of homologous recombination deficiency across multiple cancer types. | Sci Rep | 2023 | 37264024 | PubTator, text mining | PubMed |
| Prevalence of Pathogenic Germline Variants in Women with Non-Familial Unilateral Triple-Negative Breast Cancer. | Breast Care (Basel) | 2023 | 37261134 | PubTator, text mining | PubMed |
| A metabolic map of the DNA damage response identifies PRDX1 in the control of nuclear ROS scavenging and aspartate availability. | Mol Syst Biol | 2023 | 37259925 | PubTator, text mining | PubMed |
| Correspondence between functional scores from deep mutational scans and predicted effects on protein stability. | Protein Sci | 2023 | 37243972 | PubTator, text mining | PubMed |
| Therapeutic and diagnostic applications of exosomal circRNAs in breast cancer. | Funct Integr Genomics | 2023 | 37243750 | PubTator, text mining | PubMed |
| Aryl Hydrocarbon Receptor as an Anticancer Target: An Overview of Ten Years Odyssey. | Molecules | 2023 | 37241719 | PubTator, text mining | PubMed |
| Multi-Gene Next-Generation Sequencing Panel for Analysis of BRCA1/BRCA2 and Homologous Recombination Repair Genes Alterations Metastatic Castration-Resistant Prostate Cancer. | Int J Mol Sci | 2023 | 37240284 | PubTator, text mining | PubMed |
| Genomic Landscape of Normal and Breast Cancer Tissues in a Hungarian Pilot Cohort. | Int J Mol Sci | 2023 | 37239898 | PubTator, text mining | PubMed |
| Hereditary Cancer Syndromes: A Comprehensive Review with a Visual Tool. | Genes (Basel) | 2023 | 37239385 | PubTator, text mining | PubMed |
| Hereditary Breast Cancer in Romania-Molecular Particularities and Genetic Counseling Challenges in an Eastern European Country. | Biomedicines | 2023 | 37239058 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/580/papers?page=27